Top compounds associated with response to PLXND1


Feature Type Standardized
Nominal ANOVA
mRNA foretinib CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0007
mRNA Irinotecan CCLE pan-cancer AAC -0.19 0.0007
mRNA TKI258 CCLE pan-cancer AAC 0.16 0.0008
mRNA Axitinib CTRPv2 pan-cancer AAC 0.12 0.0008
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.13 0.0008
mRNA tivozanib GDSC1000 pan-cancer AAC 0.12 0.0009
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.0009
mRNA Cytarabine GDSC1000 pan-cancer AAC 0.12 0.001
mRNA AZD8055 CTRPv2 pan-cancer AAC -0.12 0.001
Download CSV